search
Back to results

Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients

Primary Purpose

Varicose Veins, Varicose Veins of Lower Limb

Status
Completed
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
GSV radiofrequency ablation with concomitant phlebectomy
Sponsored by
Pirogov Russian National Research Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Varicose Veins focused on measuring varicose veins, chiva, hemodynamic correction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • C2EpAsPrGSVa, C2,3EpAsPrGSVa
  • Reflux not lower than upper part of the calf,
  • Age more than 18 years,
  • SFJ diameter less than 15mm,
  • Incompetence of terminal-femoral valve,
  • GSV reflux more than 0,5 sec,
  • re-entry perforator on the thigh or upper part of the calf for patients in the hot-CHIVA group

Exclusion Criteria:

  • C4-C6 class of CEAP
  • Pregnancy
  • Deep vein reflux more than 1 sec
  • SSV reflux more than 0,5 sec
  • Interventions for VVs prior to the inclusion
  • Those unwilling to sign an informed consent were also included.

Sites / Locations

  • Veronika Golovina

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CHIVA group

Control group

Arm Description

43 participants. In the study group patients GSV was punctured 20-25 cm below SFJ. Radiofrequency catheter (ClosureFast) was inserted and positioned at SFJ distally to the superficial iliac circumflex vein. Four cycles were used for one segment below SFJ. After that catheter cooled down to 40C and was extracted. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.

43 participants. In the controls GSV was punctured at a distal part of a refluxing segment. Catheter was positioned at SFJ and conventional radiofrequency procedure was performed with four cycles below SFJ and two cycles for every next segment. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.

Outcomes

Primary Outcome Measures

Quality of life (QoL) was measured by ChronIc Venous Insufficiency Quality of Life (CIVIQ-20)
There are 20 questions in the CIVIQ-20, each with 5 possible answers (1 to 5), the minimum possible score being 20 and the maximum 100. In order to calculate the GIS, the difference between the final score and the minimum possible score is to be divided by the difference between the theoretical maximum and minimum scores (100-20=80), multiplied by 100.

Secondary Outcome Measures

Varicose veins recurrence
Visual recurrence of varicose veins
Leg discomfort related to CVD symptoms measured with 10-cm visual analogue scale (VAS) at 3 months
Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. The following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm).
In a study group remained GSV trunk diameter at mid- and lower thigh was measured at 1, 3, 6, 12 months after procedure
Diameter of GSV measured by ultrasound

Full Information

First Posted
May 3, 2022
Last Updated
May 12, 2022
Sponsor
Pirogov Russian National Research Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT05372146
Brief Title
Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients
Official Title
Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
September 1, 2020 (Actual)
Study Completion Date
February 27, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pirogov Russian National Research Medical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
86 patients were randomized into hot-CHIVA (n=43) and control (n=43) groups. Study group patients had undergone radiofrequency ablation (RFA) VNUS Closure - FastTM of one segment of GSV close to saphenofemoral junction. Controls had undergone whole refluxing trunk ablation. Additional phlebectomy was performed in all the patients of both groups. Primary end-point was change in quality of life (QoL) measured with CIVIQ-20 at 12 months. Secondary end-points was recurrence of varicose veins at 12 months. The investigators also measured GSV caliber at the median and distal thigh change in hot-CHIVA group.
Detailed Description
Aim - to compare GSV segmental radiofrequency ablation (hot-CHIVA) and conventional GSV ablation in varicose veins patients. This was a single-center, prospective, non-randomized, non-inferiority comparative study conducted on patients with primary varicose veins. In a study group (hot-CHIVA) GSV segmental ablation with concomitant phlebectomy was performed. Conventional GSV radiofrequency ablation was performed in a control group. Patients were enrolled from November, 2019 to February, 2021. All patients were examined clinically. Age, height, weight, body mass index, gender, side of disease, personal history of varicose veins were recorded. Medical history was taken. Disease description was made using advanced CEAP classification. Quality of life was measured by CIVIQ-20 and leg discomfort related to CVD symptoms on the operated leg was measured with a 10-cm visual analogue scale (VAS). Duplex ultrasound was performed in a standing position to access deep veins and GSV. We recorded reflux extention and presence of the re-entry perforators on the thigh or upper calf. Diameter of GSV near SFJ, at the middle, and lower part of the thigh was measured at inclusion in the both groups. Sample size The sample size was calculated considering the average values for the CIVIQ-20 quality of life questionnaire on 2nd year after the endovascular treatment and CHIVA treatment obtained by reviewing the literature. Selected parameters: first-order error (α) 5%; power 80%; boundaries of "non-inferiority limit" 2; the expected difference between the study groups of 0. Taking into account the possible dropout of patients from the study, the size of the groups is increased by 5%. The estimated sample size is 86 participants. Statistical analysis Data are presented using descriptive statistics. Normally distributed data are presented as mean with standard deviation. Not normally distributed data are presented as (Me) and interquartile range (Q1 - Q3). Two independent groups were compared with Student's t-test or Mann-Whitney test depending on data distribution. Friedman test was used to compare dependent variables. Pearson's chi-squared test or Fisher's exact test were used to compare nominal variables. A p-value of <0.05 was considered statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Varicose Veins, Varicose Veins of Lower Limb
Keywords
varicose veins, chiva, hemodynamic correction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This was a single-center, prospective, non-randomized, non-inferiority comparative study conducted on patients with primary varicose veins
Masking
Participant
Allocation
Non-Randomized
Enrollment
86 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CHIVA group
Arm Type
Experimental
Arm Description
43 participants. In the study group patients GSV was punctured 20-25 cm below SFJ. Radiofrequency catheter (ClosureFast) was inserted and positioned at SFJ distally to the superficial iliac circumflex vein. Four cycles were used for one segment below SFJ. After that catheter cooled down to 40C and was extracted. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
43 participants. In the controls GSV was punctured at a distal part of a refluxing segment. Catheter was positioned at SFJ and conventional radiofrequency procedure was performed with four cycles below SFJ and two cycles for every next segment. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.
Intervention Type
Procedure
Intervention Name(s)
GSV radiofrequency ablation with concomitant phlebectomy
Intervention Description
Radiofrequency ablation with concomitant phlebectomy
Primary Outcome Measure Information:
Title
Quality of life (QoL) was measured by ChronIc Venous Insufficiency Quality of Life (CIVIQ-20)
Description
There are 20 questions in the CIVIQ-20, each with 5 possible answers (1 to 5), the minimum possible score being 20 and the maximum 100. In order to calculate the GIS, the difference between the final score and the minimum possible score is to be divided by the difference between the theoretical maximum and minimum scores (100-20=80), multiplied by 100.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Varicose veins recurrence
Description
Visual recurrence of varicose veins
Time Frame
12 months
Title
Leg discomfort related to CVD symptoms measured with 10-cm visual analogue scale (VAS) at 3 months
Description
Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. The following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm).
Time Frame
2nd day, 7th day, 1 months, 3 months
Title
In a study group remained GSV trunk diameter at mid- and lower thigh was measured at 1, 3, 6, 12 months after procedure
Description
Diameter of GSV measured by ultrasound
Time Frame
1 months, 3 months, 6 months, 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: C2EpAsPrGSVa, C2,3EpAsPrGSVa Reflux not lower than upper part of the calf, Age more than 18 years, SFJ diameter less than 15mm, Incompetence of terminal-femoral valve, GSV reflux more than 0,5 sec, re-entry perforator on the thigh or upper part of the calf for patients in the hot-CHIVA group Exclusion Criteria: C4-C6 class of CEAP Pregnancy Deep vein reflux more than 1 sec SSV reflux more than 0,5 sec Interventions for VVs prior to the inclusion Those unwilling to sign an informed consent were also included.
Facility Information:
Facility Name
Veronika Golovina
City
Moscow
ZIP/Postal Code
109044
Country
Russian Federation

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Great Saphenous Vein Sparing Segmental Radiofrequency Ablation in Varicose Veins Patients

We'll reach out to this number within 24 hrs